{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:12:27Z","timestamp":1793056347297,"version":"4.5.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"DOI":"10.1007\/s42000-026-00801-3","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T17:59:09Z","timestamp":1782410349000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Papillary thyroid carcinoma discovered in a patient on semaglutide therapy for metabolic syndrome: a case presentation and review of current evidence"],"prefix":"10.1007","author":[{"given":"Jawad","family":"Haddadin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aus","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Nahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama","family":"Hamarneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7510-4731","authenticated-orcid":false,"given":"Fares","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"issue":"3","key":"801_CR1","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3390\/ph18030399","volume":"18","author":"R Salvador","year":"2025","unstructured":"Salvador R, Moutinho CG, Sousa C, Vinha AF, Carvalho M, Matos C (2025) Semaglutide as a GLP-1 Agonist: A Breakthrough in Obesity Treatment. Pharmaceuticals (Basel) 18(3):399. https:\/\/doi.org\/10.3390\/ph18030399","journal-title":"Pharmaceuticals (Basel)"},{"issue":"9","key":"801_CR2","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1080\/14796678.2025.2511412","volume":"21","author":"RJ MacIsaac","year":"2025","unstructured":"MacIsaac RJ (2025) Semaglutide: a key medication for managing cardiovascular-kidney-metabolic syndrome. Future Cardiol 21(9):663\u2013683. https:\/\/doi.org\/10.1080\/14796678.2025.2511412","journal-title":"Future Cardiol"},{"issue":"4","key":"801_CR3","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1089\/thy.2023.0530","volume":"34","author":"AE De Espinosa","year":"2024","unstructured":"De Espinosa AE, Brito JP, McCoy RG, Shao H, Singh Ospina N (2024) Glucagon-Like Peptide-1 Receptor Agonists and Thyroid Cancer: A Narrative Review. Thyroid 34(4):403\u2013418. https:\/\/doi.org\/10.1089\/thy.2023.0530","journal-title":"Thyroid"},{"issue":"3","key":"801_CR4","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1210\/en.2011-1864","volume":"153","author":"LW Madsen","year":"2012","unstructured":"Madsen LW, Knauf JA, Gotfredsen C, Pilling A, Sj\u00f6gren I, Andersen S et al (2012) GLP-1 receptor agonists and the thyroid: C-cell effects in mice are mediated via the GLP-1 receptor and not associated with RET activation. Endocrinology 153(3):1538\u20131547. https:\/\/doi.org\/10.1210\/en.2011-1864","journal-title":"Endocrinology"},{"key":"801_CR5","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.molmet.2019.09.010","volume":"30","author":"TD M\u00fcller","year":"2019","unstructured":"M\u00fcller TD, Finan B, Bloom SR, D\u2019Alessio D, Drucker DJ, Flatt PR, Fritsche A (2019) Glucagon-like peptide 1 (GLP-1). Mol Metab 30:72\u2013130. https:\/\/doi.org\/10.1016\/j.molmet.2019.09.010","journal-title":"Mol Metab"},{"issue":"6","key":"801_CR6","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41571-026-01135-0","volume":"23","author":"E Mannucci","year":"2026","unstructured":"Mannucci E, Dicembrini I (2026) Glucagon-like peptide 1 receptor agonists and cancer risk: the good, the bad and the unknown. Nat Rev Clin Oncol 23(6):459\u2013470. https:\/\/doi.org\/10.1038\/s41571-026-01135-0","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"801_CR7","doi-asserted-by":"publisher","first-page":"536","DOI":"10.3803\/EnM.2014.29.4.536","volume":"29","author":"MJ Jung","year":"2014","unstructured":"Jung MJ, Kwon SK (2014) Expression of glucagon-like Peptide-1 receptor in papillary thyroid carcinoma and its clinicopathologic significance. Endocrinol Metab (Seoul) 29(4):536\u2013544. https:\/\/doi.org\/10.3803\/EnM.2014.29.4.536","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"2","key":"801_CR8","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2337\/dci22-0052","volume":"46","author":"CA Thompson","year":"2023","unstructured":"Thompson CA, St\u00fcrmer T, Putting (2023) GLP-1 RAs and Thyroid Cancer in Context: Additional Evidence and Remaining Doubts. Diabetes Care 46(2):249\u2013251. https:\/\/doi.org\/10.2337\/dci22-0052","journal-title":"Diabetes Care"},{"issue":"8","key":"801_CR9","doi-asserted-by":"publisher","first-page":"4346","DOI":"10.3390\/ijms25084346","volume":"25","author":"CVI Feier","year":"2024","unstructured":"Feier CVI, Vonica RC, Faur AM, Streinu DR, Muntean C (2024) Assessment of Thyroid Carcinogenic Risk and Safety Profile of GLP1-RA Semaglutide (Ozempic) Therapy for Diabetes Mellitus and Obesity: A Systematic Literature Review. Int J Mol Sci 25(8):4346. https:\/\/doi.org\/10.3390\/ijms25084346","journal-title":"Int J Mol Sci"},{"issue":"8","key":"801_CR10","doi-asserted-by":"publisher","first-page":"4454","DOI":"10.1111\/dom.16489","volume":"27","author":"GA Silverii","year":"2025","unstructured":"Silverii GA, Marinelli C, Bettarini C, Del Vescovo GG, Monami M, Mannucci E (2025) GLP-1 receptor agonists and the risk for cancer: A meta-analysis of randomized controlled trials. Diabetes Obes Metab 27(8):4454\u20134468. https:\/\/doi.org\/10.1111\/dom.16489","journal-title":"Diabetes Obes Metab"},{"issue":"9","key":"801_CR11","doi-asserted-by":"publisher","first-page":"102834","DOI":"10.1016\/j.dsx.2023.102834","volume":"17","author":"L Nagendra","year":"2023","unstructured":"Nagendra L, Bg H, Sharma M, Dutta D (2023) Semaglutide and cancer: A systematic review and meta-analysis. Diabetes Metab Syndr 17(9):102834. https:\/\/doi.org\/10.1016\/j.dsx.2023.102834","journal-title":"Diabetes Metab Syndr"},{"issue":"2","key":"801_CR12","doi-asserted-by":"publisher","first-page":"e70038","DOI":"10.1002\/edm2.70038","volume":"8","author":"C Abi Zeid Daou","year":"2025","unstructured":"Abi Zeid Daou C, Aboul Hosn O, Ghzayel L, Mourad M (2025) Exploring Connections Between Weight-Loss Medications and Thyroid Cancer: A Look at the FDA Adverse Event Reporting System Database. Endocrinol Diabetes Metab 8(2):e70038. https:\/\/doi.org\/10.1002\/edm2.70038","journal-title":"Endocrinol Diabetes Metab"},{"key":"801_CR13","doi-asserted-by":"publisher","unstructured":"Pasternak B, Wintzell V, Hviid A, Eliasson B, Gudbj\u00f6rnsdottir S, Jonasson C et al (2024) Glucagon-like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study. BMJ e078225. https:\/\/doi.org\/10.1136\/bmj-2023-078225. .10;385","DOI":"10.1136\/bmj-2023-078225"},{"issue":"3","key":"801_CR14","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1001\/jamaoto.2024.4852","volume":"151","author":"JP Brito","year":"2025","unstructured":"Brito JP, Herrin J, Swarna KS, Singh Ospina NM, Montori VM, Toro-Tobon D et al (2025) GLP-1RA Use and Thyroid Cancer Risk. JAMA Otolaryngol Head Neck Surg 151(3):243\u2013252. https:\/\/doi.org\/10.1001\/jamaoto.2024.4852","journal-title":"JAMA Otolaryngol Head Neck Surg"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-026-00801-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42000-026-00801-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-026-00801-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T17:59:10Z","timestamp":1782410350000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42000-026-00801-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":14,"alternative-id":["801"],"URL":"https:\/\/doi.org\/10.1007\/s42000-026-00801-3","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"15 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was not required for this case report, as per institutional guidelines. Written informed consent for clinical data use was obtained from the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying clinical details.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}